Strides Pharma Science
STAR · Pharma > Pharmaceuticals & Drugs · Chairman: Arun Kumar · MD: R Ananthanarayanan · Listing date: Feb. 2, 2000 · Employees: 2390 · Bangalore · http://www.strides.com

Stock Price vs Company Growth
1d
0.2%
1w
1.8%
1m
8.6%
3m
28.3%
6m
79.0%
1y
166.3%
5y
14.4%
10y
7.7%
all
12.0%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 898 0.2%
685
912
Company Overview

Sales
3,953 Cr
Growth: 8.9%
Profit after Tax
-98.3 Cr
Growth: -63.5%
Mid Cap
8,253 Cr
P/S: 2.1x
Industry P/S: 2.6x
Fundamentals

Sales (Cr) ₹ 3,953
Growth 8.9%
EBITDA 16.9%
P/S 2.1x
Dividend 0.3%
P/E -53.2x
Book Value ₹ 10
PEG Ratio -6.0x
ROE -108.4%
P/B N/A
Shareholding Pattern

Institutions
Sbi Long Term Equity Fund
6.67 %
Aditya Birla Sun Life Trustee Private Limited
6.5 %
Life Insurance Corporation Of India P & Gs Fund
4.61 %
Route One Offshore Master Fund, L.P.
4.46 %
Route One Fund I, L.P.
2.99 %
Promoters
Pronomz Ventures Llp
18.37 %
Arun Kumar Pillai
1.54 %
K R Ravishankar
1.4 %
Karuna Business Solutions Llp
1.36 %
Shasun Leasing And Finance (P) Limited
1.12 %
Others
Increase    Decrease    No change
Company Profile Detailed

The company’s core competence is in the development and manufacture of wide range of niche and technically complex pharmaceutical products. The company is also among the world's largest soft gelatin capsule manufacturers.ProductsSoft gel capsules - The company manufactures range of soft gel in category of nutraceuticals, Rx, specialty OTCs and immunosuppressants.Steriles- Under this, it offers its products in therapeutic segments that includes beta-lactams and cephalosporins.
Investors (180)
Followers (9)